These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22115635)

  • 1. A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses.
    Berzofsky JA
    Vaccine; 2012 Jun; 30(29):4323-7. PubMed ID: 22115635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to use immune modulators in therapeutic vaccines against cancer.
    Berzofsky JA; Terabe M; Wood LV
    Semin Oncol; 2012 Jun; 39(3):348-57. PubMed ID: 22595057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
    Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
    BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine.
    Belnoue E; Mayol JF; Carboni S; Di Berardino Besson W; Dupuychaffray E; Nelde A; Stevanovic S; Santiago-Raber ML; Walker PR; Derouazi M
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31013258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells.
    Assudani D; Cho HI; DeVito N; Bradley N; Celis E
    Cancer Res; 2008 Dec; 68(23):9892-9. PubMed ID: 19047170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8
    Zahm CD; Colluru VT; McNeel DG
    Cancer Immunol Res; 2017 Aug; 5(8):630-641. PubMed ID: 28634215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of antigen-specific immune responses induced by canarypox virus vaccines.
    Bos R; van Duikeren S; van Hall T; Lauwen MM; Parrington M; Berinstein NL; McNeil B; Melief CJ; Verbeek JS; van der Burg SH; Offringa R
    J Immunol; 2007 Nov; 179(9):6115-22. PubMed ID: 17947686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells.
    Ramakrishna V; Vasilakos JP; Tario JD; Berger MA; Wallace PK; Keler T
    J Transl Med; 2007 Jan; 5():5. PubMed ID: 17254349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadly Protective CD8
    Zhang H; Zheng H; Guo P; Hu L; Wang Z; Wang J; Ju Y; Meng S
    J Virol; 2021 May; 95(12):. PubMed ID: 33827939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in virus-like particle-based vaccines for infectious diseases and cancer.
    Buonaguro L; Tagliamonte M; Tornesello ML; Buonaguro FM
    Expert Rev Vaccines; 2011 Nov; 10(11):1569-83. PubMed ID: 22043956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T-cell tolerance can be broken by an adenoviral vaccine while CD4+ T-cell tolerance is broken by additional co-administration of a Toll-like receptor ligand.
    Salucci V; Mennuni C; Calvaruso F; Cerino R; Neuner P; Ciliberto G; La Monica N; Scarselli E
    Scand J Immunol; 2006 Jan; 63(1):35-41. PubMed ID: 16398699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses.
    Smith HA; Rekoske BT; McNeel DG
    Vaccine; 2014 Mar; 32(15):1707-15. PubMed ID: 24492013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mimovirus vaccine containing survivin epitope with adjuvant IL-15 induces long-lasting cellular immunity and high antitumor efficiency.
    Yang Z; Wang L; Wang H; Shang X; Niu W; Li J; Wu Y
    Mol Immunol; 2008 Mar; 45(6):1674-81. PubMed ID: 18035418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines.
    Holst PJ; Sorensen MR; Mandrup Jensen CM; Orskov C; Thomsen AR; Christensen JP
    J Immunol; 2008 Mar; 180(5):3339-46. PubMed ID: 18292559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.
    An LL; Rodriguez F; Harkins S; Zhang J; Whitton JL
    Vaccine; 2000 Apr; 18(20):2132-41. PubMed ID: 10715528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects.
    Cho HI; Celis E
    Cancer Res; 2009 Dec; 69(23):9012-9. PubMed ID: 19903852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses.
    Shinde P; Bharat V; Rodriguez-Oquendo A; Zhou B; Vella AT
    Expert Opin Biol Ther; 2018 Oct; 18(10):1073-1083. PubMed ID: 30169979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistical toll-like receptors activated dendritic cells induce antitumor effects against carcinoembryonic antigen-expressing colon cancer.
    Hong X; Dong T; Hu J; Yi T; Li W; Zhang Z; Lin S; Niu W
    Int J Colorectal Dis; 2013 Jan; 28(1):25-33. PubMed ID: 22777000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.